Vimarsana
Biggest News Aggregation in the World

Page 6 - Biosensor Platform News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Biosensor Platform. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Biosensor Platform Today - Breaking & Trending Today

IQX Limited (NSX:IQX) Progress of Clinical Programs - ABN Newswire (@ABN_Newswire) - Vimarsana News

IQX Limited (NSX:IQX) Progress of Clinical Programs - ABN Newswire (@ABN_Newswire)

IQX Limited (NSX:IQX) Progress of Clinical Programs    Progress of Clinical ProgramsSydney, April 29, 2021 AEST (ABN Newswire) - iQX Limited (iQX Ltd) ( NSX:IQX) would like to announce that Life Science Biosensor Diagnostics Pty Ltd (LSBD) in which iQX Ltd holds a 19% equity position, has received approval from the Harvard Longwood campus Institutional Review Board (IRB) to commence a clinical validation study to test patient samples from a COVID-19 repository. The study follows a partnership with the Wyss Institute for Biologically Inspired Engineering at Harvard University (Wyss Instit...

GBS, Inc. Announces Closing of Upsized $21.6 Million Initial Public Offering - Vimarsana News

GBS, Inc. Announces Closing of Upsized $21.6 Million Initial Public Offering

NEW YORK, Dec. 28, 2020 -- GBS Inc. , a life sciences company developing non-invasive, real-time diagnostic testing in the hands of patients and their primary health practitioners at point... | January 24, 2021

GBS Inc. Announces Pricing of Initial Public Offering - Vimarsana News

GBS Inc. Announces Pricing of Initial Public Offering

GBS Inc. Announces Pricing of Initial Public Offering Will Trade on the Nasdaq Global Market Under Ticker “GBS” NEW YORK, Dec. 22, 2020 (GLOBE NEWSWIRE) — GBS Inc. (the “Company”) (Nasdaq: GBS), a life sciences company developing non-invasive, real-time diagnostic testing in the hands of patients and their primary health practitioners at point of care, today announced the pricing of its initial public offering of 1,270,589 units at a public offering price of $17.00 per unit. Each unit will immediately separate into (a) one share of the Company’s common stock (or, at the purchaserâ...

UPDATE - GBS Inc. Announces Pricing of $21.6 Million Initial Public Offering - Vimarsana News

UPDATE - GBS Inc. Announces Pricing of $21.6 Million Initial Public Offering

UPDATE – GBS Inc. Announces Pricing of $21.6 Million Initial Public Offering Will Trade on the Nasdaq Global Market Under Ticker “GBS” NEW YORK, Dec. 23, 2020 (GLOBE NEWSWIRE) — GBS Inc. (the “Company”) (Nasdaq: GBS), a life sciences company developing non-invasive, real-time diagnostic testing in the hands of patients and their primary health practitioners at point of care, today announced the pricing of its initial public offering of 1,270,589 units at a public offering price of $17.00 per unit. Each unit will immediately separate into (a) one share of the Company’s common sto...